HIV Research for Prevention Conference combining AIDS Vaccine & Microbicides

艾滋病毒预防研究会议结合艾滋病疫苗

• 批准号: 8731587
• 负责人: Eric Hunter
• 金额: $ 100万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2015-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8731587
• 关键词: AIDS Vaccines; AIDS prevention; Acquired Immunodeficiency Syndrome; Address; Advocate; Applications Grants; Archives; Area; Award; Budgets; Canada; Cities; Collaborations; Commit; Communication; Communities; Country; Developing Countries; Educational process of instructing; Ensure; Epidemic; Fees; Fertilization; Foundations; Funding; Gender; Goals; Government; Guidelines; HIV; HIV Infections; HIV vaccine; Humanities; Income; Infection; Institutes; International; Joints; Journals; Link; London; Medical Research; Participant; Peer Review; Persons; Policy Maker; Prevention; Prevention Research; Prevention strategy; Preventive Intervention; Private Sector; Process; Program Development; Public Health; Publications; Publishing; Qualifying; Reproductive Health; Research; Research Infrastructure; Research Personnel; Robin bird; Scholarship; Science; Scientist; Series; Slide; Solid; South Africa; Technology; Teleconferences; Time; TimeLine; Uganda; United States National Institutes of Health; Universities; Vaccines; Vision; Wit; Work; abstracting; base; career; college; cost; experience; insight; meetings; member; microbicide; novel strategies; posters; prevention clinical trial; programs; public health relevance; success; symposium; vaccine development; web site

DESCRIPTION (provided by applicant): The purpose of this grant application is to request funds to partially support planning, organizing and hosting HIV Research for Prevention 2014: Vaccine, Microbicide and ARV-based Prevention Science Conference (R4P2014), an international conference. R4P2014 will be the world's first and only scientific meeting dedicated to biomedical HIV prevention research. Its primary goals are to help create opportunities for trans-disciplinary interactions in biomedical prevention research; expand discussions of crosscutting issues as new HIV prevention options are developed, and increase coordination and communication among international groups. The pursuit of effective biomedical HIV prevention options has progressed further and faster in the last few years than at any time since the epidemic began. Recent breakthroughs in vaccines, ARV-based microbicides, PrEP, treatment for prevention and other prevention technologies create new opportunities to reduce the impact of the global epidemic. This progress also brings opportunity for scientific debate and creates new challenges as we continue to move HIV biomedical prevention research forward. Most importantly, these advances teach us that effective HIV prevention will require a combination of approaches. Reflective of this new approach, we propose a new, broader prevention research conference for 2014, HIV Research for Prevention. This first bi-annual meeting will take place 28-31 October 2014 at the Cape Town International Conference Centre in Cape Town, South Africa. This international conference will bring together researchers, advocates, clinicians, policy makers, private sector partners and public health experts to present, discuss, and debate the latest research in ARV-based prevention, vaccines and related areas of HIV prevention. It will build on and link to the successes of the past bi-annual Microbicide and annual AIDS Vaccine conferences it will replace. The conference will drive greater coordination, cross-fertilization and increased collaboration. It will also provide a forum to address cross-cutting issues, emphasizing the importance of combination prevention, and it will break down any existing research siloes between different prevention technologies. R4P 2014 will therefore have a significant impact on the advancement of scientific research in unique prevention areas with the potential to make significant progress in the prevention of HIV infection. The conference will attract between 1,200-1,500 members of the HIV prevention community and will provide 200 full and 100 partial scholarships as well as subsidized registration rates for early-career and lower-middle income country (LMIC) scientists. Information presented at the conference will be disseminated to give free, worldwide access to all who are unable to attend in person. Peer-reviewed abstracts will be published online in an open access journal, and posters will be available online as e-posters. All sessions will be available as webcasts, including free downloads of slides and audio on the conference web site.

说明（由申请人提供）：本拨款申请的目的是请求资金部分支持规划、组织和主办 2014 年艾滋病毒预防研究：疫苗、杀微生物剂和抗逆转录病毒药物预防科学会议 (R4P2014)，这是一个国际会议。 R4P2014将是世界上第一个也是唯一一个致力于艾滋病毒生物医学预防研究的科学会议。其主要目标是帮助为生物医学预防研究中的跨学科互动创造机会；随着新的艾滋病毒预防方案的制定，扩大对跨领域问题的讨论，并加强国际团体之间的协调和沟通。过去几年，寻求有效的生物医学艾滋病毒预防方案的进展比该流行病爆发以来的任何时候都更进一步、更快。最近在疫苗、抗逆转录病毒杀微生物剂、PrEP、预防治疗和其他预防技术方面取得的突破为减少全球流行病的影响创造了新的机会。随着我们继续推进艾滋病毒生物医学预防研究，这一进展也为科学辩论带来了机会，并带来了新的挑战。最重要的是，这些进展告诉我们，有效的艾滋病毒预防需要采取多种方法相结合。为了反映这一新方法，我们提议在 2014 年召开一次新的、更广泛的预防研究会议，即艾滋病毒预防研究。第一次两年一度的会议将于 2014 年 10 月 28 日至 31 日在南非开普敦开普敦国际会议中心举行。这次国际会议将汇集研究人员、倡导者、临床医生、政策制定者、私营部门合作伙伴和公共卫生专家，介绍、讨论和辩论基于抗逆转录病毒药物的预防、疫苗和艾滋病毒预防相关领域的最新研究。它将以过去两年一度的杀菌剂会议和年度艾滋病疫苗会议的成功为基础并与之相关，并将取代它。会议将推动加强协调、交叉促进和加强合作。它还将提供一个论坛 为了解决跨领域问题，强调组合预防的重要性，它将打破不同预防技术之间现有的研究孤岛。因此，R4P 2014将对独特预防领域的科学研究进步产生重大影响，有可能在预防艾滋病毒感染方面取得重大进展。此次会议将吸引 1,200-1,500 名艾滋病预防界成员参加，并将为早期职业生涯和中低收入国家 (LMIC) 科学家提供 200 份全额奖学金和 100 份部分奖学金以及注册费补贴。会议上提供的信息将被传播，以便所有无法亲自参加会议的人可以在全球范围内免费访问。经过同行评审的摘要将在开放获取期刊上在线发布，海报将以电子海报形式在线提供。所有会议都将以网络广播形式提供，包括在会议网站上免费下载幻灯片和音频。